Web Results



Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell ...

RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info ...


SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for SUTENT®.

Sunitinib: MedlinePlus Drug Information - National Library of Medicine


Sunitinib may cause serious or life-threatening damage to the liver. Tell your doctor if you have or have ever had liver disease or problems with your liver.

Sutent (Sunitinib Malate) Drug Information: Description, User ...


Learn about the prescription medication Sutent (Sunitinib Malate), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

Sunitinib (Sutent®) - Cancer information - Macmillan Cancer Support


Find out more about sunitinib (also called Sutent®), which may be used to treat a type of kidney cancer called renal cell carcinoma (RCC), gastrointestinal ...

DrugBank: Sunitinib


Sunitinib inhibits cellular signaling by targeting multiple RTKs. These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial ...

Sunitinib Malate - National Cancer Institute


Oct 5, 2006 ... This page contains brief information about sunitinib malate and a collection of links to more information about the use of this drug, research ...

Sunitinib: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for sunitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Sutent (sunitinib) medical facts from Drugs.com


Sunitinib can cause severe or fatal effects on your liver. You will need frequent blood tests to check your liver function during treatment. Call your doctor if you ...

Sunitinib Malate (Professional Patient Advice) - Drugs.com


Professional guide for Sunitinib Malate. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.

Sunitinib Highlights
SUNITINIB (soo NI ti nib) is a chemotherapy drug. It targets a specific protein within cancer cells and stops the cancer cells from growing. It is used to treat specific digestive tract tumors called GISTs, advanced kidney cancer, and certain pancreatic neuroendocrine tumors. More »
Source: healthline.com
More Info

Sunitinib - Chemotherapy Drugs - Chemocare


Trade Name: Sutent <sup>®</sup> Other Name: SU11248. Drug Type: Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions ...

Sunitinib (Sutent) | Cancer Research UK


May 12, 2015 ... Read about the cancer treatment drug sunitinib, otherwise known as Sutent, including what it is, how it works and possible side effects.

Definition of sunitinib malate - NCI Drug Dictionary - National ...


sunitinib malate: Patient Information: The orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity.